
Biotech Growth Trust Plc
(LSE) BIOG
Biotech Growth Trust Plc Financials at a Glance
Market Cap
£279.66M
Revenue (TTM)
£59.04M
Net Income (TTM)
£47.59M
EPS (TTM)
£5.58
P/E Ratio
2.59
Dividend
£0.00
Beta (Volatility)
0.00 (Low)
Dividend
£0.00
Beta (Volatility)
0.00 (Low)
Price
£14.33
Volume
6,746
Open
£14.56
Price
£14.33
Volume
6,746
Open
£14.56
Previous Close
£14.48
Daily Range
£14.30 - £14.56
52-Week Range
£7.02 - £14.56
Estimated Earnings Date
Nov 25, 2025
Dividend
£0.00
Beta (Volatility)
0.00 (Low)
Price
£14.33
Volume
6,746
Open
£14.56
Previous Close
£14.48
Daily Range
£14.30 - £14.56
52-Week Range
£7.02 - £14.56
Estimated Earnings Date
Nov 25, 2025
BIOG News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biotech Growth Trust Plc
Industry
Capital Markets
Sector
FinancialsEmployees
0
Website
biotechgt.comHeadquarters
New York City, NY 10022, US
BIOG Financials
Key Financial Metrics (TTM)
Gross Margin
98.21%
Operating Margin
97.68%
Net Income Margin
96.47%
Return on Equity
48.26%
Return on Capital
44.82%
Return on Assets
43.10%
Earnings Yield
38.61%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
£279.66M
Shares Outstanding
19.31M
Volume
6.75K
Avg. Volume
61.05K
Financials (TTM)
Gross Profit
£55.40M
Operating Income
£52.25M
EBITDA
£51.71M
Operating Cash Flow
-£11.66M
Capital Expenditure
£0.00
Free Cash Flow
-£11.66M
Cash & ST Invst.
£0.00
Total Debt
£12.32M
Biotech Growth Trust Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
£63.82M
-29.7%
Gross Profit
£62.50M
-28.6%
Gross Margin
97.93%
N/A
Market Cap
£279.66M
N/A
Market Cap/Employee
N/A
N/A
Employees
0
N/A
Net Income
£60.83M
-31.1%
EBITDA
£61.66M
-30.5%
Quarterly Fundamentals
Total Cash
£0.00
-100.0%
Total Debt
£12.32M
-73.8%
Accounts Receivable
£11.00M
-24.2%
Inventory
£0.00
N/A
Long Term Debt
£0.00
N/A
Short Term Debt
£12.32M
-73.8%
Return on Assets
43.10%
N/A
Return on Invested Capital
45.49%
N/A
Free Cash Flow
-£3.46M
-46.0%
Operating Cash Flow
-£3.46M
-46.0%